Clinician Responsible for Training and Review: Emergency Department Consultant

Similar documents
Clinician Responsible for Training and Review: Emergency Department Consultant

Continence PGD transdermal oxybutynin Kentera patch 36mg

Patient Group Direction for the supply and/or administration of Ibuprofen 400mg tablets to patients attending NHS Borders services

Developed By Name Signature Date

SAMPLE. PGD Reviewed by: Chris Faldon, John Maloney, Tim Patterson, Adrian MacKenzie, Claire Stein

Document Details. Patient Group Direction

SAMPLE. This direction was authorised on 4/5/2007. The direction will be reviewed by 4/5/2009

patient group direction

Patient Group Direction for SALBUTAMOL INHALER (Version 02) Valid From 1 October September 2019

Expiry Date: July 2009 Template Version: Page 1 of 7

SAMPLE. PGD reviewed by: Dr Tim Patterson, Chris Faldon, John Maloney, Adrian Mackenzie

Document Details. Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml

Developed By Name Signature Date

Author of PGD: Adrian MacKenzie, Lead Pharmacist, Primary and Community Care.

This document expires on Patient Group Direction No. VI 5

Continence PGD - Oxybutynin 5mg Modified Release

This document expires on Patient Group Direction No. VI 7

This document expires on Patient Group Direction No. VI 11

Expiry Date: September 2009 Template Version: Page 1 of 7

Document Details Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No Local Ref (optional) Main points the

PATIENT GROUP DIRECTION (PGD)

Borders. Patient Group Direction (PGD) Development Policy For NHS Borders

patient group direction

This document expires on Patient Group Direction Number VI 19

Document Details. Patient Group Direction

PATIENT GROUP DIRECTION PROCEDURE

GG&C PGD ref no: 2016/1408 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

Administration of Short-Acting Beta-agonists for Acute Episodes of Moderate or Severe Asthma by Practice Nurses

SALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

PATIENT GROUP DIRECTION. Oral (live attenuated) Typhoid Vaccine (Ty21a) (Vivotif )

Clinical Condition Indication:

Administration of Tuberculin Purified Protein Derivative (PPD) 2TU per 0.1ml to patients attending BCG clinics with identified TB at risk factors.

GG&C PGD ref no: 2018/1603 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

PATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY OR ADMINISTRATION OF LEVONORGESTREL 1500 MICROGRAM TABLET (e.g LEVONELLE 1500 ) PGD

Community Psychiatric Nurse. Consultant Psychiatrist, Substance Misuse Services

Patient Group Direction No. VI 17. Kathy Wakefield/Lisa Murray. General Practices & TRFT. Relevant Clinical Lead

GG&C PGD ref no: 2016/1338 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

PGD5717. Director of Quality & Clinical Performance. Therèsa Moyes

Clinical Condition Indication:

GG&C PGD ref no: 2017/1427 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

PATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF ORAL DIAZEPAM TO WORKING AGE AND OLDER PEOPLE IN THE COMMUNITY

PATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY OF DOXYCYCLINE 100MG TABLETS FOR THE FIRST-LINE TREATMENT OF CHLAMYDIA TRACHOMATIS INFECTION

Patient Group Direction for Doxycycline (Tetracycline) Version: 01 Start Date: October 2015 Expiry Date: October 2018

Prescription only medicines (POMs)

HEPATITIS A + TYPHOID VACCINE

Version Number: 5. Patient Group Direction drawn up by: Chief Pharmacist - Strategy. Group direction authorised by:

Patient Group Direction for GLUCAGON (Version 02) Valid From 1 October September 2019

GG&C PGD ref no: 2018/1589 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

PATIENT GROUP DIRECTION (PGD) Supply of potassium iodide 65mg tablets to adults and children exposed to, or at risk of exposure to radioactive iodine

by registered nurses employed by NHS Hertfordshire or Hertfordshire GP Practices and signatories to the PGD

NEW ZEALAND CONSUMER MEDICINE INFORMATION. Salbutamol (as sulfate) 100 micrograms per actuation inhalation aerosol

PGD No Administration of Human Papillomavirus Vaccine (HPV) Types 6, 11, 16 and 18 - Gardasil - September 2012

Patient Group Direction for LIDOCAINE INJECTION (Version 02) Valid From 1 October September 2019

CALDERDALE PRIMARY CARE TRUST

patient group direction

for adults engaged with the Family Wellbeing Service Isle of Wight In Community Pharmacy for Isle of Wight Public Health Commissioned Services

NHS Lothian Patient Group Direction Version: 006

Job Title Name Signature Date. Director of Nursing Angela Wallace Signed Angela Wallace 30/6/2014

National Patient Group Direction for the Supply of Azithromycin, by Pharmacists, for the Treatment of Uncomplicated Chlamydia Infection

Patient Group Direction For the supply and administration of

patient group direction

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. APO-SALVENT CFC FREE salbutamol sulphate inhalation aerosol

National Patient Group Direction for the Supply of Azithromycin, by Pharmacists, for the Treatment of Uncomplicated Chlamydia Infection

Template Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices

Patient Group Direction For the supply and administration of

Patient Group Direction For the supply and administration of

patient group direction

PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017

VENTOLIN EVOHALER. Salbutamol

PATIENT GROUP DIRECTION

Beclazone 50, 100, 250 micrograms CFC-Free Inhaler

z_4-/01/11 ,c.,u V clf..rm-t PGD for the administration of Phytomenadione (Konakion MM Paediatric 2mg/0.2ml solution for injection) via the oral route

patient group direction

Policy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical Commissioning Group

Ventamol CFC-Free 100 micrograms, Pressurised Inhalation, Suspension (Salbutamol)

Care Homes - Homely Remedies Protocol

PGD for the administration of: Intradermal injections of Sterile Water for pain relief

Patient Group Direction for PROCHLORPERAZINE (Version 02) Valid From 1 October September 2019

Protocol for the use of emergency salbutamol inhalers in schools

Guidelines for the use of Nebulised Colistemethate Sodium (Colomycin) Injection () in Pseudomonas aeruginosa Lung Infections in Adults

Package leaflet: Information for the user. Qvar 50 & 100 aerosol Beclometasone Dipropionate

PATIENT GROUP DIRECTIONS POLICY

Rexair Inhaler Consumer Medicine Information

GG&C PGD ref no: 2018/1601 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

Darland High School Policy

Clinical Condition Indication:

NHS Lothian Patient Group Direction Version: 007. Title: Levonorgestrel 1500mcg for Emergency Contraception

THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:

Patient Group Direction Hepatitis A vaccine Version: Hepatitis A 2015 Start Date: 1 st July 2015 Expiry Date:30 th June 2018

patient group direction

Patient Group Direction For The Administration Of H1N1 (Swine Flu) vaccine

patient group direction

Brook Green Centre for Learning. Policy and Guidance for Supporting Pupils with Medical Needs

Patient Group Directions (PGDs)

NEW ZEALAND DATA SHEET

PATIENT GROUP DIRECTION FOR THE SUPPLY OF ORLISTAT BY COMMUNITY PHARMACISTS

Patient Group Direction for Measles, Mumps & Rubella Vaccine. PGD Version No.: 7/2013.

INTERNAL ONLY STANDING ORDER EMERGENCY DEPARTMENTS SALBUTAMOL SULFATE Administration by Accredited Emergency Nurses for symptom relief of asthma

Transcription:

Patient Group Direction for the Supply of Salbutamol Inhaler to patients receiving treatment from NHS Borders Emergency Department/Out of Hours/Minor Injury Units This document authorises the supply or administration of Salbutamol Inhaler by Registered Nurses to patients who meet the criteria for inclusion under the terms of the document The Registered Nurses seeking to supply Salbutamol Inhaler must ensure that all patients have been screened and meet the criteria before supply takes place The purpose of this Patient Group Direction is to allow management of asthma in NHS Borders by Registered Nurses in the absence of medical support PGD previously approved: November 2004 This direction was authorised on: November 2010 The direction will be reviewed by: November 2012 Clinician Responsible for Training and Review: Emergency Department Consultant PGD Reviewed by: Jacques Kerr, Beverly Meins NHS Borders PGD for Salbutamol Replacement Inhaler 1

Patient Group Direction for the administration of Salbutamol Inhaler without a prescription for a named individual by Registered Nurses employed by NHS Borders. 1. This Patient Group Direction relates to the following specific preparation: Name of medicine, Strength, Salbutamol CFC free Aerosol Inhaler Formulation 100 micrograms per actuation Legal status Prescription Only Medicine (POM) Storage Store below 30 C (86 F). Protect from frost and direct sunlight. As with most inhaled medications in aerosol canisters, the therapeutic effect of this medication may decrease when the canister is cold. The canister should not be broken, punctured or burnt, even when apparently empty. Dose 1-2 puffs Route/method By inhalation Frequency 4 times a day either regularly or as required Total dose Quantity Maximum 4 times daily (8 puffs/800 (Maximum/Minimum) micrograms daily) Maximum supply 1 inhaler Advice to Patients Advise on appropriate use with review of inhaler technique. Advise on the importance of always carrying the inhaler and/or obtaining repeat prescription in a timely manner. If asthmatic and using salbutamol regularly then recommend need for review by asthma nurse or doctor Relevant Warnings Anaphylaxis to be treated as per the NHS Borders anaphylaxis protocol/pgd. Hypersensitivity reactions including paradoxical bronchospasm and urticaria May cause fine tremor (usually the hands) Nervous tension Headache Arrhythmias, palpitations, tachycardia Mouth and throat irritation NHS Borders PGD for Salbutamol Replacement Inhaler 2

Follow up Arrangements 2. Clinical condition Clinical Condition to be treated Criteria for inclusion Criteria for exclusion Action if excluded or declines Interactions with other medicaments and other forms of interaction Referral Patient should arrange for supply of regular inhaler through usual channels as soon as possible. Patient with a previous diagnosis of asthma who requires the use of a short acting bronchodilator. Patient with a previous diagnosis of asthma or COPD, requesting a supply of a Salbutamol inhaler, having run out of their regularly prescribed Salbutamol inhaler Patient unable to obtain an emergency supply from a local pharmacy. Patient must currently be prescribed Salbutamol inhaler by their GP. The nurse must be reasonably assured that the request is genuine. Patient did not satisfy the nurse of genuine need. Patient has not previously been prescribed Salbutamol inhaler. Patient does not have a previous diagnosis of asthma or COPD. The patient must be referred to a doctor and the reason for referral should be documented. It is the responsibility of the staff using this PGD to ensure that treatment with this medication is appropriate. If in any doubt advice should be sought and recorded before the drug is administered. Salbutamol and non-selective betablocking drugs such as Propranolol should not normally be used together. The patient may be referred to a doctor at any stage, if this is necessary, in the professional opinion of the nurse. Patients should be referred to a doctor if treatment proves to be ineffective in relieving the symptoms. 3. Records: As per department protocol 1. The following records should be kept (either paper or computer based) NHS Borders PGD for Salbutamol Replacement Inhaler 3

The GP practice, clinic, hospital, and ward or department The patient name and CHI number The medicine name, dose, route, time of dose(s), and where appropriate, start date, number of doses and or period of time, for which the medicine is to be supplied or administered Drug batch number and expiry The signature and printed name of the approved healthcare professional that supplied or administered the medicine The patient group direction title and/or number If patient met the inclusion criteria and if the exclusion criteria was assessed Quantity supplied / received and current stock balance 2. Preparation, audit trail, data collection and reconciliation Stock balances should be reconcilable with receipts, administration records and disposals on a patient by patient basis. 3. Storage Store below 30 C (86 F). Protect from frost and direct sunlight. As with most inhaled medications in aerosol canisters, the therapeutic effect of this medication may decrease when the canister is cold. The canister should not be broken, punctured or burnt, even when apparently empty. 4. Professional Responsibility All Health Professionals will ensure they have the relevant training and are competent in all aspects of medication use, including contraindications and the recognition and treatment of adverse effects. He/she will attend training updates as appropriate. For those involved in immunization, regular anaphylaxis updates are mandatory. Nurses will have due regard for the NMC Code of Professional Conduct, standards for conduct, performance and ethics (2008) and NMC Standards for Medicines Management (2008) 5. References British National Formulary (BNF) current edition http://bnf.org/bnf/index.htm Borders Joint Formulary (BJF) http://intranet/new_intranet/microsites/index.asp?siteid=65&uid=1 SPC Ventolin Evohaler www.medicines.org.uk NHS Borders PGD for Salbutamol Replacement Inhaler 4

Patient Group Direction for provision and/or administration of Salbutamol Inhaler by health professionals employed by NHS Borders This Patient Group Direction is approved for use by the under-signed : Job Title Name Signed Date Senior Doctor/Dentist for relevant clinical area NHS Borders Director of Pharmacy Ross Cameron Alison Wilson NHS Borders Senior Health Isabel Swan Professional for Clinical Area PGD AUTHORISED ON. /. /.. BY NHS BORDERS ADTC/CHAIRPERSON Signed by ADTC CHAIRPERSON:.. Name: The Health Professionals named below, being employees of NHS Borders based at the Emergency Department/Out of Hours/Minor Incident Units are authorised to provide and/or administer this medication under this Patient Group Direction and agree to provide and/or administer this medication in accordance with this Patient Group Direction Name of Health Professional Job Title Signed Date NHS Borders PGD for Salbutamol Replacement Inhaler 5